Prosper N. Boyaka

4.9k total citations
98 papers, 3.6k citations indexed

About

Prosper N. Boyaka is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Prosper N. Boyaka has authored 98 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 25 papers in Molecular Biology and 17 papers in Infectious Diseases. Recurrent topics in Prosper N. Boyaka's work include Immune Cell Function and Interaction (18 papers), Immune Response and Inflammation (18 papers) and T-cell and B-cell Immunology (15 papers). Prosper N. Boyaka is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Immune Response and Inflammation (18 papers) and T-cell and B-cell Immunology (15 papers). Prosper N. Boyaka collaborates with scholars based in United States, Japan and France. Prosper N. Boyaka's co-authors include Jerry R. McGhee, James W. Lillard, Estelle Cormet‐Boyaka, Kohtaro Fujihashi, Mariarosaria Marinaro, Romy Fischer, Raymond J. Jackson, Hiroshi Kiyono, M. Dubarry and Joost J. Oppenheim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Prosper N. Boyaka

98 papers receiving 3.6k citations

Peers

Countries citing papers authored by Prosper N. Boyaka

Since Specialization

Citations

This map shows the geographic impact of Prosper N. Boyaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prosper N. Boyaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prosper N. Boyaka more than expected).

Fields of papers citing papers by Prosper N. Boyaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prosper N. Boyaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prosper N. Boyaka. The network helps show where Prosper N. Boyaka may publish in the future.

Co-authorship network of co-authors of Prosper N. Boyaka

This figure shows the co-authorship network connecting the top 25 collaborators of Prosper N. Boyaka. A scholar is included among the top collaborators of Prosper N. Boyaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prosper N. Boyaka. Prosper N. Boyaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Intravenous Antimicrobial Drugs on the Equine Fecal Microbiome 2022 ·Animals ·(unknown), (unknown), Gregory Habing, Prosper N. Boyaka, (unknown), Márcio Costa, Diego E. Gómez, Ramiro E. Toribio	14
2	SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern 2022 ·Proceedings of the National Academy of Sciences ·Mijia Lu, (unknown), Yuexiu Zhang, Chengjin Ye, Piyush Dravid, Jun‐Gyu Park, (unknown), Sheetal Trivedi, (unknown), Himanshu Sharma, (unknown), Supranee Chaiwatpongsakorn, Xueya Liang, Jacob S. Yount, Prosper N. Boyaka, Mark E. Peeples, Luis Martínez‐Sobrido, Amit Kapoor, Jiànróng Lǐ	32
3	Targeting the EGFR‐ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del 2022 ·The FASEB Journal ·(unknown), Rachael E. Rayner, Sheng‐Wei Chang, (unknown), Sun Hee Kim, Amit Sharma, Prosper N. Boyaka, Estelle Cormet‐Boyaka	10
4	Inhibition of elastase enhances the adjuvanticity of alum and promotes anti–SARS-CoV-2 systemic and mucosal immunity 2021 ·Proceedings of the National Academy of Sciences ·Eunsoo Kim, (unknown), (unknown), Cong Zeng, Sun Hee Kim, (unknown), (unknown), Namal P. M. Liyanage, Shristi Ghimire, Jiànróng Lǐ, Gourapura J. Renukaradhya, Abhay R. Satoskar, Amal O. Amer, Shan‐Lu Liu, Estelle Cormet‐Boyaka, Prosper N. Boyaka	20
5	Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus 2021 ·PLoS Pathogens ·Miaoge Xue, Yuexiu Zhang, Haitao Wang, (unknown), Mijia Lu, Sadeem Ahmad, (unknown), Olivia Harder, Zijie Zhang, Jiangbo Wei, Phylip Chen, Youling Gao, Mark E. Peeples, Amit Sharma, Prosper N. Boyaka, Chuan He, Sun Hur, Stefan Niewiesk, Jiànróng Lǐ	27
6	Caspase-11 regulates lung inflammation in response to house dust mites 2021 ·Cellular Immunology ·Arwa Abu Khweek, (unknown), Eunsoo Kim, (unknown), Kathrin Krause, Kylene P. Daily, Shady Estfanous, (unknown), Asmaa Badr, (unknown), Mostafa Eltobgy, Kara N. Corps, (unknown), Xiaoli Zhang, Mikhail A. Gavrilin, Prosper N. Boyaka, Amal O. Amer	5
7	Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection 2020 ·Journal of Virology ·Anzhong Li, Miaoge Xue, (unknown), Jingyou Yu, Mijia Lu, Chao Shan, Xueya Liang, (unknown), Pei‐Yong Shi, Mark E. Peeples, Prosper N. Boyaka, Shan‐Lu Liu, Jiànróng Lǐ	10
8	Insights Into Mucosal Innate Immune Responses in House Dust Mite-Mediated Allergic Asthma 2020 ·Frontiers in Immunology ·Arwa Abu Khweek, Eunsoo Kim, (unknown), Amal O. Amer, Prosper N. Boyaka	46
9	Cathepsin K Localizes to Equine Bone In Vivo and Inhibits Bone Marrow Stem and Progenitor Cells Differentiation In Vitro 2017 ·PubMed ·Hayam Hussein, Prosper N. Boyaka, (unknown), (unknown), (unknown), Mohamed Azab, Alicia L. Bertone	7
10	An NF-κB–Independent and Erk1/2-Dependent Mechanism Controls CXCL8/IL-8 Responses of Airway Epithelial Cells to Cadmium 2011 ·Toxicological Sciences ·Estelle Cormet‐Boyaka, (unknown), (unknown), (unknown), Fatemat Hassan, Payal Mehta, Susheela Tridandapani, Jeanette I. Webster Marketon, Prosper N. Boyaka	43
11	A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system 2007 ·Vaccine ·(unknown), Sung‐Youl Ko, Kyoo‐A Lee, Hyun‐Jeong Ko, Yoon Sook Lee, Kohtaro Fujihashi, Prosper N. Boyaka, Sanghee Kim, Taisuke Horimoto, Mi‐Na Kweon, Chang‐Yuil Kang	77
12	Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens 2006 ·The Journal of Immunology ·Alexandra Duverger, Raymond J. Jackson, (unknown), Romy Fischer, Angela Tafaro, Stephen H. Leppla, Kohtaro Fujihashi, Hiroshi Kiyono, Jerry R. McGhee, Prosper N. Boyaka	53
13	A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking 2006 ·The Journal of Immunology ·Yukari Hagiwara, Yuki I. Kawamura, Kosuke Kataoka, (unknown), Raymond J. Jackson, Katsuhiro Komase, Taeko Dohi, Prosper N. Boyaka, Yoshifumi Takeda, Hiroshi Kiyono, Jerry R. McGhee, Kohtaro Fujihashi	33
14	Oral and Nasal Sensitization Promote Distinct Immune Responses and Lung Reactivity in a Mouse Model of Peanut Allergy 2005 ·American Journal Of Pathology ·Romy Fischer, Jerry R. McGhee, Huong Vu, T. Prescott Atkinson, Raymond J. Jackson, Daniel Tomé, Prosper N. Boyaka	44
15	Peanut-lupine antibody cross-reactivity is not associated to cross-allergenicity in peanut-sensitized mouse strains 2005 ·International Immunopharmacology ·(unknown), M. Dubarry, M Rautureau, Najat Aattouri, Prosper N. Boyaka, Daniel Tomé	17
16	Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen 2003 ·The Journal of Immunology ·Prosper N. Boyaka, Angela Tafaro, Romy Fischer, Stephen H. Leppla, Kohtaro Fujihashi, Jerry R. McGhee	113
17	Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit 2003 ·The Journal of Immunology ·Prosper N. Boyaka, Mari Ohmura, Kohtaro Fujihashi, Toshiya Koga, Masafumi Yamamoto, Mi‐Na Kweon, Yoshifumi Takeda, Raymond J. Jackson, Hiroshi Kiyono, Yoshikazu Yuki, Jerry R. McGhee	44
18	Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic Immunity 2001 ·The Journal of Immunology ·Prosper N. Boyaka, Mariarosaria Marinaro, Raymond J. Jackson, Frederik W. van Ginkel, Estelle Cormet‐Boyaka, Kevin L. Kirk, Charlotte R. Kensil, Jerry R. McGhee	46
19	Strategies for mucosal vaccine development. 1999 ·American Journal of Tropical Medicine and Hygiene ·Prosper N. Boyaka, Mariarosaria Marinaro, John L. VanCott, Ichiro Takahashi, Keiko Fujihashi, Márcio Yamamoto, Frederik W. van Ginkel, R J Jackson, Hiroshi Kiyono, Jerry R. McGhee	35
20	Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics 1998 ·Gastroenterology ·Shigetada Kawabata, Prosper N. Boyaka, (unknown), Kohtaro Fujihashi, Masafumi Yamamoto, Jerry R. McGhee, Hiroshi Kiyono	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact